Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Neuroscience Letters
|
July 24, 2003
The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease
Sofia A Oliveira, Eden R Martin, William K Scott, et al.
Neurology. Genetics
|
August 6, 2020
Disease-modifying effects of an <i>SCAF4</i> structural variant in a predominantly <i>SOD1</i> ALS cohort
Julia Pytte, Loren L Flynn, Ryan S Anderton, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 6, 2004
Periventricular leukomalacia is common after neonatal cardiac surgery
Kristin K Galli, Robert A Zimmerman, Gail P Jarvik, et al.
Neurobiology of Aging
|
February 11, 2014
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936
Donald M Lyall, Sarah E Harris, Mark E Bastin, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 14, 2019
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
Daniel K Burns, Carl Chiang, Kathleen A Welsh-Bohmer, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 28, 2015
APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds
Donald M Lyall, Susana Muñoz Maniega, Sarah E Harris, et al.
Plos One
|
November 22, 2013
Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936
Donald M Lyall, Natalie A Royle, Sarah E Harris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 28, 2014
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles
Allen D Roses, Michael W Lutz, Ann M Saunders, et al.
The Lancet. Neurology
|
June 19, 2021
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Daniel K Burns, Robert C Alexander, Kathleen A Welsh-Bohmer, et al.
Neuroscience Letters
|
July 6, 2004
Analysis of European mitochondrial haplogroups with Alzheimer disease risk
Joelle M van der Walt, Yulia A Dementieva, Eden R Martin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Neuroscience Letters
|
July 24, 2003
The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease
Sofia A Oliveira, Eden R Martin, William K Scott, et al.
Neurology. Genetics
|
August 6, 2020
Disease-modifying effects of an <i>SCAF4</i> structural variant in a predominantly <i>SOD1</i> ALS cohort
Julia Pytte, Loren L Flynn, Ryan S Anderton, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
March 6, 2004
Periventricular leukomalacia is common after neonatal cardiac surgery
Kristin K Galli, Robert A Zimmerman, Gail P Jarvik, et al.
Neurobiology of Aging
|
February 11, 2014
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936
Donald M Lyall, Sarah E Harris, Mark E Bastin, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
November 14, 2019
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial
Daniel K Burns, Carl Chiang, Kathleen A Welsh-Bohmer, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
August 28, 2015
APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds
Donald M Lyall, Susana Muñoz Maniega, Sarah E Harris, et al.
Plos One
|
November 22, 2013
Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936
Donald M Lyall, Natalie A Royle, Sarah E Harris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 28, 2014
African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles
Allen D Roses, Michael W Lutz, Ann M Saunders, et al.
The Lancet. Neurology
|
June 19, 2021
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Daniel K Burns, Robert C Alexander, Kathleen A Welsh-Bohmer, et al.
Neuroscience Letters
|
July 6, 2004
Analysis of European mitochondrial haplogroups with Alzheimer disease risk
Joelle M van der Walt, Yulia A Dementieva, Eden R Martin, et al.
Page
of 6